Novo Nordisk Total Long-Term Assets 2010-2024 | NVO

Novo Nordisk total long-term assets for the quarter ending September 30, 2024 were $29.816B, a 29.33% increase year-over-year.

  • Novo Nordisk total long-term assets for 2023 were $25.387B, a 34.74% increase from 2022.
  • Novo Nordisk total long-term assets for 2022 were $18.842B, a 8.74% increase from 2021.
  • Novo Nordisk total long-term assets for 2021 were $17.328B, a 42.97% increase from 2020.

Novo Nordisk Total Long-Term Assets 2010-2024 | NVO

  • Novo Nordisk total long-term assets for 2023 were $25.387B, a 34.74% increase from 2022.
  • Novo Nordisk total long-term assets for 2022 were $18.842B, a 8.74% increase from 2021.
  • Novo Nordisk total long-term assets for 2021 were $17.328B, a 42.97% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B